CONSULTING AGREEMENTConsulting Agreement • March 30th, 2016 • Vermillion, Inc. • In vitro & in vivo diagnostic substances
This Consulting Agreement (“Agreement”) confirms the understanding between David Schreiber (“Schreiber”) and Vermillion, Inc. (“the Company”) pursuant to which the Company has retained Schreiber to provide consulting services of the type described below (collectively, the “Services”), on the terms and subject to the conditions set forth herein, in connection with the matters referred to herein.
